{"name":"James Brugarolas","slug":"james-brugarolas","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNRldjUDltY0xHWUZCaml5RExjWElmbU1vQ3ZYcV9XWmR4RmNWeHRtRVlIU05EQ195NzUtdGdNQkVpWVFURHlGejNkcW9CbGR5R3Y3eWEwZTFuZW9qZ2RQSnlHVFhMeGc3WHhGbjgxOHhSa1dpZkV0V2NIQTRHQUs4TmVvYXZOOWtWMXAzZQ?oc=5","date":"2024-04-23","type":"pipeline","source":"UT Southwestern Medical Center","summary":"Drug targeting clear cell renal cell carcinoma shows promising approach: Newsroom - UT Southwestern Medical Center","headline":"Drug targeting clear cell renal cell carcinoma shows promising approach: Newsroom","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOOE5RaTNnVEZ1NzFoQ0pveHpmUFBGMVN5TWVRUlBuLUI5d0lUY3ZNZ3NGZWFYZDlVdTFob3NPQ1lkeDJ4VGNCb0R0bFYzWDA0ZG5EaGdvOW45S2lRU05ZSy1VdWFCWnVkWFhOTldzSGZjWlo3R0V4MU11dU1hM2hyTm13dXg2Q3VkMDd3NEUzZk91MjlXbXlCY1JDV1R0NmVUUzAydXltLXY?oc=5","date":"2023-12-15","type":"regulatory","source":"UT Southwestern Medical Center","summary":"Drug developed by UTSW spinoff approved for metastatic kidney cancer: Newsroom - UT Southwestern Medical Center","headline":"Drug developed by UTSW spinoff approved for metastatic kidney cancer: Newsroom","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPUFRzSjI2MHl3T1NESzQtOVF5UWJScXd4V0pmMVJWX2REYkwtZEJmb0ZQT1ctcXY2Q0xxWE41bjhVMkt4ODZZb2dmQVQ5UFh2NjRCUDEzT2I4SUxwNWd1QUt6a1lxejRfVDFYX01LMFhEYlZQTGkzajJqV2FxdFFTS2h2X05YOFZoUmVoWGphV0tYUzhVVkRLaHMxMWk?oc=5","date":"2022-10-03","type":"pipeline","source":"UT Southwestern Medical Center","summary":"Tackling resistance to HIF2 drugs with an RNA-based therapy: Newsroom - UT Southwestern Medical Center","headline":"Tackling resistance to HIF2 drugs with an RNA-based therapy: Newsroom","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}